Keywords
spinocerebellar ataxias - vestibular diseases - chronic disease
Palavras-chave
ataxias espinocerebelares - doenças vestibulares - doença crçnica
Hereditary ataxias are a heterogeneous group of neurodegenerative diseases that are characterized by the presence of progressive cerebellar ataxia and have initial clinical manifestations such as deterioration of balance and coordination, as well as ocular disorders[1],[2],[3],[4]. Based on genetic inheritance, ataxias can be divided into: 1) autosomal recessive cerebellar ataxias (ARCAs); 2) autosomal dominant cerebellar ataxias, or dominant spinocerebellar ataxias (SCAs); 3) X-linked hereditary ataxia (related to the X chromosome); and 4) mitochondrial ataxias[5].
Within the group of ARCAs, we highlight Friedreich's ataxia. It is a rare neurodegenerative disease, progressive in nature, and has autosomal recessive early onset in most cases[6],[7],[8].
The mutation responsible for the disease is located on chromosome nine, where there is a GAA trinucleotide expansion in the X25 gene. The affected gene has the function of encoding the mitochondrial protein, frataxin, that is involved in iron metabolism[7],[8],[9]. The deficit of this protein causes the accumulation of iron within the mitochondria disturbing the mitochondrial respiratory chain and increasing oxidative stress[6],[9],[10]. The first symptoms are usually observed in childhood or the early teen years; however, in some cases the diagnosis can be made before two or after 20 years of age. The main features of the disease are: ataxia (impaired coordination) that initially affects the lower limbs and then the upper, absence of tendon reflexes and weakness in the lower limbs, dysarthria, loss of distal deep sensation, and bilateral Babinski sign. Nerve conduction studies show sensory axonal neuropathy[9],[11]. Other features associated with this medical condition are: nystagmus, optic atrophy, hearing loss, atrophy in the hands and distal lower limbs, scoliosis, pes cavus, and hammer toes[6],[11].
Within the group of SCAs, we highlight types 2, 3, 6, 7 and 10, which are of interest in this study. The most common clinical symptoms in SCAs present as gait and appendage ataxia (dysmetria, diadochokinesia in limbs, intentional tremors), dysarthria, nystagmus, ophthalmoplegia, dysphagia, hearing loss (in some patients), pyramidal signs, lower motor neuron syndrome, cognitive dysfunction, epilepsy, visual disturbances (pigmentary retinopathy), peripheral neuropathy, dementia and movement disorders (including parkinsonism, dystonia, myoclonus and chorea)[1],[12].
The SCA types 2, 3, 6, and 7 are related to unstable CAG repeat expansions in the respective gene, and are classified as polyglutamine disorders[1],[12],[13],[14]. The SCA10 is caused by a repeat expansion of an ATTCT pentanucleotide, in the intron 9 of the gene located in the chromosome 22q13.3.
Different clinical and neuropathological studies in hereditary ataxias have shown that each specific genetic entity has a constellation of signs and symptoms that are related to the duration of the disease and the size of trinucleotide repeat expansion. Thus, the combination of molecular genetic data and clinical signs provide useful information serving as the basis for the genotypic and phenotypic classification of ataxias[15].
Hereditary ataxias are part of a list of diseases that, by their manifestations and impairment areas, can lead to vestibular disorders, and the labyrinthine examination is an important tool in the confirmation of vestibular disorders and their relationship with the central nervous system[16].
The aim of this study was to describe and compare the vestibular findings most evident among the hereditary ataxias, as well as correlate their clinical features with the nervous structures affected in this disease.
METHODS
The research protocol was approved by the Ethics Committee on Research Involving Human Subjects (registration number CEP n°. 832.502/2014) following the Brazil Platform. All examinations were performed after formal consent forms were obtained from all participants.
The study had a retrospective cross-sectional design. Seventy-five patients with ataxia were evaluated, 56 with SCAs (26 females and 30 males) and 19 with ARCAs (eight females and 11 males). Among them, 37 patients had a genetically-proven diagnosis of SCAs, and six of Friedreich's ataxia. The diagnosis of ataxia was made by analysis of clinical and genetic tests using the polymerase chain reaction[17],[18]. This reaction is based on the fact that the oligonucleotides (primers) hybridize specifically to a DNA template strand enabling the production of multiple copies of specific DNA sequences[19].
The ages of the SCA patients ranged from 18 to 70 years (mean, 42.7 ± 12.4 years). The duration of the disease ranged from one to 18 years (mean, 8.4 ± 4.1 years) and the ages of the ARCA patients ranged from six to 63 (mean, 36.7 ± 14.3 years). The duration of the disease ranged from three to 38 years (mean, 16.2 ± 9.2 years), as shown in [Tables 1] and [2].
Table 1
Summary of patient demographics and genetic diagnoses in SCAs.
Patient
|
Age/sex (years)
|
SCA type
|
Disease duration (years)
|
Chromosomal locus of abnormality
|
Gene affected
|
Mutation type
|
Protein affected
|
SARA
|
1
|
42/M
|
SCA3
|
12
|
14q32.1
|
ATXN3
|
CAG
|
Ataxin-3
|
4
|
2
|
48/F
|
SCA3
|
15
|
14q32.1
|
ATXN3
|
CAG
|
Ataxin-3
|
10
|
3
|
43/M
|
SCA3
|
12
|
14q32.1
|
ATXN3
|
CAG
|
Ataxin-3
|
4.5
|
4
|
41/M
|
SCA3
|
8
|
14q32.1
|
ATXN3
|
CAG
|
Ataxin-3
|
10.5
|
5
|
48/F
|
SCA3
|
10
|
14q32.1
|
ATXN3
|
CAG
|
Ataxin-3
|
10.5
|
6
|
53/M
|
SCA3
|
13
|
14q32.1
|
ATXN3
|
CAG
|
Ataxin-3
|
13
|
7
|
50/F
|
SCA3
|
8
|
14q32.1
|
ATXN3
|
CAG
|
Ataxin-3
|
9.5
|
8
|
30/F
|
SCA3
|
9
|
14q32.1
|
ATXN3
|
CAG
|
Ataxin-3
|
11
|
9
|
42/M
|
SCA3
|
10
|
14q32.1
|
ATXN3
|
CAG
|
Ataxin-3
|
7.5
|
10
|
45/M
|
SCA3
|
15
|
14q32.1
|
ATXN3
|
CAG
|
Ataxin-3
|
11
|
11
|
51/M
|
SCA3
|
7
|
14q32.1
|
ATXN3
|
CAG
|
Ataxin-3
|
1.5
|
12
|
45/M
|
SCA3
|
3
|
14q32.1
|
ATXN3
|
CAG
|
Ataxin-3
|
25.5
|
13
|
32/F
|
SCA3
|
5
|
14q32.1
|
ATXN3
|
CAG
|
Ataxin-3
|
10
|
14
|
46/F
|
SCA3
|
11
|
14q32.1
|
ATXN3
|
CAG
|
Ataxin-3
|
7
|
15
|
49/M
|
SCA2
|
11
|
12q24.1
|
ATXN2
|
CAG
|
Ataxin-2
|
33
|
16
|
42/F
|
SCA2
|
8
|
12q24.1
|
ATXN2
|
CAG
|
Ataxin-2
|
21.5
|
17
|
54/F
|
SCA2
|
11
|
12q24.1
|
ATXN2
|
CAG
|
Ataxin-2
|
28
|
18
|
38/M
|
SCA2
|
8
|
12q24.1
|
ATXN2
|
CAG
|
Ataxin-2
|
4.0
|
19
|
41/M
|
SCA2
|
12
|
12q24.1
|
ATXN2
|
CAG
|
Ataxin-2
|
4.5
|
20
|
36/M
|
SCA2
|
3
|
12q24.1
|
ATXN2
|
CAG
|
Ataxin-2
|
21
|
21
|
18/M
|
SCA2
|
2
|
12q24.1
|
ATXN2
|
CAG
|
Ataxin-2
|
18
|
22
|
44/F
|
SCA2
|
3
|
12q24.1
|
ATXN2
|
CAG
|
Ataxin-2
|
21
|
23
|
30/F
|
SCA2
|
10
|
12q24.1
|
ATXN2
|
CAG
|
Ataxin-2
|
4
|
24
|
42/M
|
SCA2
|
12
|
12q24.1
|
ATXN2
|
CAG
|
Ataxin-2
|
9.5
|
25
|
59/M
|
SCA6
|
13
|
19q13.1
|
CACNA1A
|
CAG
|
CACNA1A
|
17.5
|
26
|
57/F
|
SCA6
|
5
|
19q13.1
|
CACNA1A
|
CAG
|
CACNA1A
|
4
|
27
|
49/M
|
SCA7
|
13
|
3p14.1
|
ATXN7
|
CAG
|
Ataxin-7
|
35
|
28
|
47/F
|
SCA7
|
10
|
3p14.1
|
ATXN7
|
CAG
|
Ataxin-7
|
16
|
29
|
52/F
|
SCA10
|
16
|
22q13.3
|
ATXN10
|
ATTCT
|
Ataxin-10
|
7
|
30
|
30/M
|
SCA10
|
4
|
22q13.3
|
ATXN10
|
ATTCT
|
Ataxin-10
|
9
|
31
|
37/F
|
SCA10
|
3
|
22q13.3
|
ATXN10
|
ATTCT
|
Ataxin-10
|
7
|
32
|
49/F
|
SCA10
|
6
|
22q13.3
|
ATXN10
|
ATTCT
|
Ataxin-10
|
16
|
33
|
46/M
|
SCA10
|
10
|
22q13.3
|
ATXN10
|
ATTCT
|
Ataxin-10
|
13
|
34
|
27/F
|
SCA10
|
3
|
22q13.3
|
ATXN10
|
ATTCT
|
Ataxin-10
|
14
|
35
|
70/M
|
SCA10
|
13
|
22q13.3
|
ATXN10
|
ATTCT
|
Ataxin-10
|
4
|
36
|
54/M
|
SCA10
|
11
|
22q13.3
|
ATXN10
|
ATTCT
|
Ataxin-10
|
10
|
37
|
56/F
|
SCA10
|
12
|
22q13.3
|
ATXN10
|
ATTCT
|
Ataxin-10
|
10
|
38
|
63/F
|
Und.
|
10
|
-
|
-
|
-
|
-
|
7
|
39
|
48/M
|
Und:
|
18
|
-
|
-
|
-
|
-
|
16
|
40
|
58/F
|
Und.
|
10
|
-
|
-
|
-
|
-
|
4.5
|
41
|
35/F
|
Und.
|
5
|
-
|
-
|
-
|
-
|
9
|
42
|
45/F
|
Und.
|
9
|
-
|
-
|
-
|
-
|
9
|
43
|
24/M
|
Und.
|
2
|
-
|
-
|
-
|
-
|
21
|
44
|
27/M
|
Und.
|
7
|
-
|
-
|
-
|
-
|
7
|
45
|
20/M
|
Und.
|
1
|
-
|
-
|
-
|
-
|
9.5
|
46
|
32/M
|
Und.
|
5
|
-
|
-
|
-
|
-
|
18.5
|
47
|
22/M
|
Und.
|
8
|
-
|
-
|
-
|
-
|
9.5
|
48
|
22/M
|
Und.
|
7
|
-
|
-
|
-
|
-
|
16
|
49
|
62/M
|
Und.
|
3
|
-
|
-
|
-
|
-
|
8
|
50
|
66/M
|
Und.
|
12
|
-
|
-
|
-
|
-
|
9.5
|
51
|
18/F
|
Und.
|
4
|
-
|
-
|
-
|
-
|
16
|
52
|
23/M
|
Und.
|
1
|
-
|
-
|
-
|
-
|
10.5
|
53
|
37/F
|
Und.
|
9
|
-
|
-
|
-
|
-
|
10.5
|
54
|
48/F
|
Und.
|
8
|
-
|
-
|
-
|
-
|
11
|
55
|
48/F
|
Und.
|
8
|
-
|
-
|
-
|
-
|
25
|
56
|
51 /F
|
Und.
|
7
|
-
|
-
|
-
|
-
|
25.5
|
SCAs: dominant spinocerebellar ataxias; SCA: spinocerebellar ataxia; Und.: undetermined; M: male; F: female; SARA: scale for the assessment and rating of ataxia.
Table 2
Summary of patient demographics and genetic diagnoses in ARCAs.
Patient
|
Age/sex (years)
|
ARCA type
|
Disease duration (years)
|
Chromosomal locus of abnormality
|
Gene affected
|
Mutation type
|
Protein affected
|
SARA
|
1
|
43/M
|
FA
|
25
|
9 q13-q21.1
|
X25
|
GAA
|
Frataxin
|
21
|
2
|
41/M
|
FA
|
7
|
9 q13-q21.1
|
X25
|
GAA
|
Frataxin
|
10
|
3
|
30/F
|
FA
|
18
|
9 q13-q21.1
|
X25
|
GAA
|
Frataxin
|
8
|
4
|
24/M
|
FA
|
8
|
9 q13-q21.1
|
X25
|
GAA
|
Frataxin
|
10.5
|
5
|
29/M
|
FA
|
13
|
9 q13-q21.1
|
X25
|
GAA
|
Frataxin
|
14
|
6
|
17/M
|
FA
|
3
|
9 q13-q21.1
|
X25
|
GAA
|
Frataxin
|
13
|
7
|
63/F
|
Und.
|
38
|
-
|
-
|
-
|
-
|
7
|
8
|
06/F
|
Und.
|
6
|
-
|
-
|
-
|
-
|
19
|
9
|
37/F
|
Und.
|
19
|
-
|
-
|
-
|
-
|
28
|
10
|
41/F
|
Und.
|
20
|
-
|
-
|
-
|
-
|
11
|
11
|
27/F
|
Und.
|
12
|
-
|
-
|
-
|
-
|
1.5
|
12
|
25/F
|
Und.
|
12
|
-
|
-
|
-
|
-
|
25.5
|
13
|
55/F
|
Und.
|
30
|
-
|
-
|
-
|
-
|
7
|
14
|
44/M
|
Und.
|
10
|
-
|
-
|
-
|
-
|
3.5
|
15
|
55/M
|
Und.
|
12
|
-
|
-
|
-
|
-
|
28
|
16
|
37/M
|
Und.
|
17
|
-
|
-
|
-
|
-
|
4.0
|
17
|
51/M
|
Und.
|
30
|
-
|
-
|
-
|
-
|
9.5
|
18
|
27/M
|
Und.
|
10
|
-
|
-
|
-
|
-
|
16
|
19
|
46/M
|
Und.
|
18
|
-
|
-
|
-
|
-
|
10
|
ARCA: autosomal recessive cerebellar ataxia; Und.: undetermined; M: male; F: female; FA: Friedreich's ataxia; SARA: scale for the assessment and rating of ataxia.
Included in the survey were patients without otoscopic alterations, and excluded were patients with musculoskeletal changes that prevented the examination.
The patients were subjected to the following procedures:
-
Anamnesis: a questionnaire was given with an emphasis on otoneurological signs and symptoms.
-
Otorhinolaryngological assessment: this was performed to rule out any alteration that could affect the test.
-
Vestibular assessment: evaluation of the vestibular function comprises many labyrinthine function and ocular tests. The first part of our patients' evaluation was clinical and consisted of a systematic search for spontaneous, gaze, and positional nystagmus. The second part consisted of interpretation of the vectoeletronystagmography test result, which is the objective register of the variations in the corneoretinal potentials, captured by sensitive electrodes. The vectoeletronystagmography test comprises calibration of ocular movements, search for spontaneous and gaze nystagmus, the oscillatory tracking test, an optokinetic nystagmus search, and rotatory and caloric tests. We performed the vectoeletronystagmography using three-channel equipment (Berger Eletromedicina, model VN316, made in São Paulo, Brazil), a rotating chair (Ferrante, model COD 14200, made in São Paulo, Brazil), a visual stimulator (Neurograff Eletromedicina, model EV VEC, São Paulo, Brazil), and an air caloric stimulator (Neurograff Eletromedicina, model NGR 05, São Paulo, Brazil).
We compared our results with normal standards, obtained from epidemiological studies in the Brazilian population[20],[21]. The criteria used to analyze each test, as well as to distinguish central from peripheral vestibulopathy, are shown in [Table 3].
Table 3
Normal standards and criteria used to analyze the vestibular tests and distinguish central from peripheral20,21.
Variable
|
Normal Vestibular Exam
|
Peripheral Vestibular Exam
|
Central Vestibular Exam
|
Position nystagmus (Brandt & Daroff's maneuver)
|
Absent
|
Present (rotatory, horizontal rotatory, and oblique) with latency, paroxysm, weariness, and vertigo
|
Present (vertical inferior, superior, rotatory, horizontal rotatory, and oblique), without latency, paroxysm, weariness, and vertigo
|
Calibration of the ocular movements
|
Regular
|
Regular
|
Irregular (alterations in latency, accuracy, and velocity of the saccadic movements)
|
Spontaneous nystagmus
|
Present (< 7degrees/sec) with closed eyes; absent with open eyes.
|
Present (> 7 degrees/sec) with closed eyes; absent with open eyes.
|
Present with open eyes (vertical inferior, superior, rotatory, horizontal rotatory, oblique, cyclic, dissociated, and convergence-retraction)
|
Gaze nystagmus
|
Absent
|
Absent
|
Present, unidirectional, bidirectional, or mixed; presents a variety of nystagmus types
|
Oscillatory track
|
Types I and II
|
Type III
|
Type IV (pathognomonic); alterations of morphology and gain
|
Optokinetic nystagmus
|
Symmetrical, < 20 degrees/sec
|
Asymmetrical, > 20 degrees/sec, having superimposed spontaneous nystagmus with open eyes that justifies this alteration
|
Asymmetrical, > 20 degrees/sec, absent and reduced
|
Rotation test
|
> 33%, after stimulation of the lateral and superior semicircular ducts
|
> 33%, after stimulation of the lateral and superior semicircular ducts
|
> 33%, after stimulation of the lateral and superior semicircular ducts and absence of induced oblique nystagmus
|
Air caloric test
|
Absolute value: between 2 and 24 degrees/sec
|
Absolute value: < 2 degrees/sec (hyporeflexia),
|
Absolute value: < 2 degrees/sec (hyporeflexia), > 24 degrees/sec (hyperreflexia) and areflexia
|
Relative values:
|
> 24 degrees/sec (hyperreflexia) and areflexia
|
Relative values:
|
Labyrinth preponderance < 41%
|
Relative values:
|
Labyrinth preponderance >41%
|
Nystagmus directional preponderance < 36%
|
Labyrinth preponderance > 41%
|
Nystagmus directional preponderance > 36% (Jongkees formula).
|
|
Nystagmus directional preponderance > 36% (Jongkees formula)
|
Different nystagmus types may be observed: dissociated, inverted, perverted, and absence of the fast component of the nystagmus
|
Inhibiting effect of ocular fixation
|
Present
|
Present
|
Absent
|
Statistical analysis
We applied the two-proportion z-test to check the most evident symptoms, check which tests presented the most alterations and compare the results of the vestibular examination (analyzing normal and abnormal results) in SCAs and ARCAs and compare them with each other.
We used the chi-squared test for SCAs and Fisher's exact test for ARCAs, to compare the results of the vestibular examination (analyzing the normal and altered results with gender as the variable). A value of 0.05 or 5% was established as the rejection level for the null hypothesis.
RESULTS
The most frequent complaints in the anamnesis were: gait imbalance (71.9% for SCAs and 52.6% for ARCAs), dysarthria (49.1% for SCAs and 36.8% for ARCAs), dizziness (43.8% for SCAs and 57.8% for ARCAs) and dysphagia (36.8% for both types of hereditary ataxia). It was found that headache was only mentioned by patients with an ARCA (42.1%), as shown in [Table 4].
Table 4
Symptoms in 75 patients with SCAs and ARCAs.
Symptoms
|
SCAs
|
ARCAs
|
No. patients
|
Frequency (%)
|
No. patients
|
Frequency (%)
|
Gait imbalance
|
41
|
71.9
|
10
|
52.6
|
Dysarthria
|
28
|
49.1
|
7
|
36.8
|
Dizziness
|
25
|
43.8
|
11
|
57.8
|
Dysphagia
|
21
|
36.8
|
7
|
36.8
|
Dysphonia
|
19
|
33.3
|
-
|
-
|
Hearing Loss
|
18
|
31.5
|
3
|
15.7
|
Headaches
|
14
|
24.5
|
8
|
42.1
|
Falling
|
14
|
24.5
|
6
|
31.5
|
Tingling in extremities
|
14
|
24.5
|
3
|
15.7
|
Diplopia
|
13
|
22.8
|
6
|
31.5
|
Tinnitus
|
13
|
22.8
|
-
|
-
|
Depression
|
12
|
21.0
|
4
|
21.0
|
Anxiety
|
11
|
19.2
|
4
|
21.0
|
Pain, radiated to shoulder, arm
|
10
|
17.5
|
5
|
26.3
|
Double vision
|
10
|
17.5
|
-
|
-
|
Tremors
|
9
|
15.7
|
6
|
31.5
|
Pain, difficulty in neck movement
|
9
|
15.7
|
4
|
21.0
|
Insomnia
|
8
|
14.0
|
1
|
5.2
|
Fatigue
|
8
|
14.0
|
5
|
26.3
|
Migraine
|
5
|
8.7
|
-
|
-
|
Taste alteration
|
-
|
-
|
1
|
5.2
|
Olfactory alteration
|
-
|
-
|
1
|
5.2
|
Cracking neck
|
-
|
-
|
3
|
15.7
|
SCAs: dominant spinocerebellar ataxias; ARCAs: autosomal recessive cerebellar ataxias; n: patients; %: frequency
In the application of the two-proportion z-test, it was shown that there was no significant difference in the proportions of patients in both hereditary ataxias for the most common symptoms: gait imbalance (p = 0.1253), dysarthria (p = 0.3546), dizziness (p = 0.2933) and dysphagia (p = 1.0000). But the same test revealed that gait imbalance occurred in a higher proportion of cases in relation to the other symptoms, showing a statistical significance (p = 0.0142*).
The frequency of abnormal findings in the vestibular evaluation in both types of hereditary ataxias are shown in [Table 5]. It can be observed in the total values that bilateral vestibular hyporeflexia and saccadic dysmetria were more prevalent for SCAs at 73.2% and 62.5% respectively, while the frequency for ARCAs was 47.3% and 15.7% respectively. There was no postrotatory nystagmus in either of the hereditary ataxias. However, multiple semi-spontaneous nystagmus and asymmetrical optokinetic nystagmus were found at 50% and 29%, respectively, in the last two tests for SCAs, while for the ARCAs there was a frequency of 36.8% in each of these tests. For ARCAs, spontaneous nystagmus with open eyes and bilateral vestibular hyperreflexia showed an alteration in 21% of patients.
Table 5
Frequency of abnormal findings in the vestibular evaluation in patients with SCAs and ARCAs.
Altered results
|
SCAs
|
ARCAs
|
SCA 2
|
SCA 3
|
SCA 6
|
SCA 7
|
SCA 10
|
Und.
|
SCAsT
|
FA
|
Und.
|
ARCAT
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
Bilateral labyrinthine hyporeflexia
|
5
|
50.0
|
13
|
92.8
|
2
|
100.0
|
2
|
100.0
|
5
|
55.5
|
14
|
73.6
|
41
|
73.2
|
3
|
50.0
|
6
|
46.1
|
9
|
47. 3
|
Saccadic dysmetria
|
7
|
70.0
|
9
|
64.2
|
1
|
50.0
|
1
|
50.0
|
6
|
66.6
|
11
|
578
|
35
|
62.5
|
2
|
33.4
|
1
|
7.6
|
3
|
15.7
|
Rotational nystagmus absent
|
5
|
50.0
|
9
|
64.2
|
1
|
50.0
|
2
|
100.0
|
2
|
22.2
|
9
|
473
|
28
|
50.0
|
3
|
50.0
|
4
|
30.7
|
7
|
36.8
|
Multiple gaze nystagmus
|
-
|
0.0
|
4
|
28.5
|
1
|
50.0
|
1
|
50.0
|
5
|
55.5
|
5
|
26.3
|
16
|
29.0
|
4
|
67.0
|
3
|
23.0
|
7
|
36.8
|
Optokinetic asymmetrical nystagmus
|
2
|
20.0
|
8
|
57.1
|
-
|
0.0
|
2
|
100.0
|
2
|
22.2
|
2
|
10.5
|
16
|
29.0
|
3
|
50.0
|
4
|
30.7
|
7
|
36.8
|
Bidirectional gaze nystagmus
|
-
|
0.0
|
2
|
14.2
|
-
|
0.0
|
-
|
0.0
|
1
|
11.1
|
3
|
15.7
|
6
|
11.0
|
-
|
-
|
-
|
-
|
-
|
-
|
Positional nystagmus
|
1
|
10.0
|
-
|
0.0
|
1
|
50.0
|
-
|
0.0
|
1
|
11.1
|
2
|
10.5
|
5
|
9.0
|
-
|
-
|
-
|
-
|
-
|
-
|
Unidirectional gaze nystagmus
|
2
|
20.0
|
1
|
7.1
|
1
|
50.0
|
-
|
0.0
|
-
|
0.0
|
-
|
0.0
|
4
|
7.2
|
-
|
-
|
-
|
-
|
-
|
-
|
Unilateral labyrinthine hyporeflexia
|
1
|
10.0
|
-
|
0.0
|
-
|
0.0
|
-
|
0.0
|
-
|
0.0
|
3
|
15.7
|
4
|
7.2
|
-
|
-
|
-
|
-
|
-
|
-
|
Spontaneous nystagmus with open eyes
|
-
|
0.0
|
1
|
7.1
|
1
|
50.0
|
-
|
0.0
|
-
|
0.0
|
1
|
5.2
|
3
|
5.4
|
2
|
33.4
|
2
|
15.3
|
4
|
21.0
|
Unilateral labyrinthine hyperreflexia
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1
|
16.7
|
-
|
-
|
1
|
5.2
|
Bilateral labyrinthine hyperreflexia
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
4
|
30.7
|
4
|
21.0
|
SCAs: dominant spinocerebellar ataxias; Und: undetermined; SCAsT:dominant spinocerebellar ataxias total; FA: Friedreich's ataxia; ARCAs: autosomal recessive cerebellar ataxias; ARCAT: autosomal recessive cerebellar ataxia total; n: patients; %: frequency.
The application of the two-proportion z-test revealed a significant difference between the proportions of patients with bilateral vestibular hyporeflexia and absence of post-rotatory nystagmus for the dominant SCAs total (p = 0.0138*) and ARCAs total (p = 0.0431*). Comparing the patients in both SCA total and ARCA total groups, the difference was significant only for saccadic dysmetria (p = 0.0009*).
The frequency of the vestibular test results in both hereditary ataxias, highlights the central vestibular dysfunction in all ataxias, as shown in [Table 6].
Table 6
Frequency of the vestibular exam results in SCAs and ARCAs.
Vestibular exam
|
SCAs
|
ARCAs
|
SCA 2
|
SCA 3
|
SCA 6
|
SCA 7
|
SCA 10
|
Und.
|
SCAsT
|
FA
|
Und.
|
ARCAT
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
Central vestibular dysfunction
|
6
|
60.0
|
11
|
78.5
|
2
|
100.0
|
2
|
100.0
|
6
|
66.7
|
14
|
73.7
|
41
|
73.2
|
4
|
66.6
|
7
|
53.8
|
11
|
579
|
Peripheral vestibular dysfunction
|
1
|
10.0
|
3
|
21.5
|
-
|
0.0
|
-
|
0.0
|
-
|
0.0
|
3
|
15.8
|
7
|
12.5
|
2
|
33.4
|
4
|
30.8
|
6
|
31.6
|
Normal vestibular exam
|
3
|
30.0
|
-
|
0.0
|
-
|
0.0
|
-
|
0.0
|
3
|
33.3
|
2
|
10.5
|
8
|
14.3
|
-
|
-
|
2
|
15.4
|
2
|
10.5
|
Total
|
10
|
100.0
|
14
|
100.0
|
2
|
100.0
|
2
|
100.0
|
9
|
100.0
|
19
|
100.0
|
56
|
100.0
|
6
|
100.0
|
13
|
100.0
|
19
|
100.0
|
SCAs: dominant spinocerebellar ataxias; Und: undetermined; SCAsT: dominant spinocerebellar ataxias total; ARCAs: autosomal recessive cerebellar ataxias; FA: Friedreich's ataxia; ARCAT: autosomal recessive cerebellar ataxia total; n: patients; %: frequency
The application of the two-proportion z-test showed a significant difference between the proportions of altered and normal results in SCAs total (p = 0.0000*) and ARCAs total (p = 0.0000*).
Regarding gender, the vestibular examination for SCAs showed alterations in males in 90% of cases and in females in 81% of cases. In the ARCAs, this alteration occurred in 83.4% of males and 100% of females, as indicated in [Table 7].
Table 7
Distribution of patients with SCAs and ARCAs according to the results of the vestibular examination and gender.
Exam result
|
SCAs
|
ARCAs
|
Male
|
Female
|
Total
|
Male
|
Female
|
Total
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
n
|
%
|
Abnormal
|
27
|
90.0
|
21
|
81.0
|
48
|
85.7
|
10
|
83.4
|
7
|
100.0
|
17
|
89.5
|
Normal
|
3
|
10.0
|
5
|
19.0
|
8
|
14.3
|
2
|
16.6
|
-
|
-
|
2
|
10.5
|
Total
|
30
|
100.0
|
26
|
100.0
|
56
|
100.0
|
12
|
100.0
|
7
|
100.0
|
19
|
100.0
|
SCAs: dominant spinocerebellar ataxias; ARCAs: autosomal recessive cerebellar ataxias; n: patients; %: frequency
The application of the chi-squared test showed that there was no significant relationship between altered and normal examinations in males and females (p = 0.5141) for SCAs, and the application of Fisher's exact test showed the same kind of result for ARCAs (p = 0.3860). Comparing results of altered and normal exams (both sexes) for SCA and ARCA groups resulted in no statistical significance (p = 0.5723).
DISCUSSION
The symptoms most commonly reported by patients in both types of hereditary ataxia in the multiplicity of its clinical forms have been observed by different authors. Among the most common manifestations that may arise during the course of the disease were gait imbalance, dysarthria, dizziness and dysphagia[1],[12]. Nacamagoe et al.[22] reported that vestibular dysfunction in combination with cerebellar atrophy could contribute significantly to the onset of gait instability, which was part of the initial symptomatology of ataxias.
Houssay[23] observed in SCA patients that the medial longitudinal fasciculus consisted largely of fibers derived from the vestibular nuclei and was involved in reflexes that allowed the eye to adjust to head movements. Information on the position of the head reach the medial longitudinal fasciculus through its connections with the vestibular nuclei. Before that, the author stated that the medial longitudinal fasciculus fibers terminate in the nuclei of oculomotor nerves III, IV and VI, paired with cranial nerves on the same and opposite sides, which explained the appearance of nystagmus in vestibular symptomatology.
In patients with Friedreich's ataxia, Oppenheimer[24] observed that the dentate nucleus displayed a moderate loss of neurons and the middle and superior cerebellar peduncles showed reductions in size. Furthermore, a loss of Purkinje cells in the cerebellar vermis and upper neurons in the corresponding portion of the inferior olivary nucleus was verified. The dentate nucleus usually had a severe cell loss. The vestibular and auditory systems were also affected by increased gliosis, especially at the level of the medial vestibular, cochlear and superior olivary nuclei. In addition, the author stated that the nuclei of cranial nerves VII, X and XII also showed a reduction in cell numbers, resulting in weakness of the face muscles, dysarthria and dysphagia. The globus pallidus and subthalamic nuclei were also affected; however, the striatum, thalamus and substantia nigra were spared. The cerebellar cortex was usually unchanged.
Regarding the vestibular examination, the alteration with the highest prevalence in both hereditary ataxias was bilateral vestibular hypofunction with 73.2% in SCAs and 47.3% in ARCAs. Saccadic dysmetria and a lack of response in the rotational test (62.5% and 50%) were the other most common alterations observed for SCAs. For ARCAs, rotary, optokinetic and semi-spontaneous nystagmus were the other most common alterations, present in 36.8% of patients. It is noteworthy that several alterations were observed in the various tests that make up the inner ear examination in both types of hereditary ataxias; the ones mentioned above were those that were most prevalent.
Although it is known that oculomotor abnormalities in patients with cerebellar dysfunction exist, it is also known that the cerebellum influences the maintenance of the eccentric portion of the eye, responsible for the smooth pursuit in eye movements, as well as the modulation in amplitude of saccades and visual suppression of caloric nystagmus[1].
The most common alterations in other studies[16],[25] were the presence of positional nystagmus, irregular eye movement calibration, spontaneous rebound nystagmus, bidirectional and multiple semi-spontaneous nystagmus, abolition of optokinetic nystagmus, pendular tracking type IV vestibular hyperfunction, absence of inhibitory effect of eye fixation, and Aubry signs in the Barany test. In the damaged neuronal structures, it is known that there is vestibular hypofunction, but little is known about when and why it occurs. A study by Fahey et al.[26] evaluated 20 patients with Friedreich's ataxia and observed that, despite the normal saccadic speed present, latency was essentially extended. In addition, vestibular alterations were found with a marked reduction in the vestibulo-ocular reflex.
A pathology study[27] of the vestibular complex and its association with its fiber bundles in four patients with SCAs, revealed that the five-core complex (interstitial, lateral, medial, spinal and superior vestibular nuclei) had suffered neurodegeneration resulting from the disease. This indicated that all bundles of fibers associated with the ascending tract of Deiters inputs, juxtarestiform body, lateral and medial vestibulospinal tracts, medial longitudinal fasciculus, and the vestibular portion of cranial nerve VIII all suffered widespread neuronal loss and atrophy that caused demyelination of the structures. These lesions may explain the brainstem changes, postural instability with imbalance, oculomotor deficits and the presence of the pathological vestibulo-ocular reflex.
Zeigelboim et al.[16] stated that the loss of hair cells of the ampullary crests and maculae, a decline in the number of nerve cells in the vestibular (or Scarpa's) ganglion, the degeneration of the otoliths, reduced labyrinthine blood flow, progressive depression of neural stability, and the reduction in compensation capacity in the vestibulo-ocular reflex and vestibulospinal reflexes all contribute to the reduction of the speed of the eye tracking motion and rotational and caloric hyporeactivity of the both peripheral and central vestibular systems – characteristics presenting in both hereditary ataxias. Luis et al.[28] pointed to the vestibulo-ocular reflex alteration as a neurophysiological biomarker for disease severity.
Other studies[16],[24] reported that lesions in the cerebellar vermis caused ataxia of the upper limbs, head tremors, dysmetria, and trembling eye movements. It was this part of the anatomy that showed electrical activity along the length of the eye muscles and neck.
In the present study, when comparing the results of the vestibular examination in both hereditary ataxias, we observed a significant difference in central vestibular dysfunction. These findings agree with other studies[25] that showed involvement of the central vestibular system, and stress the importance of vestibular evaluations in diseases affecting the posterior fossa. Some authors[26] stressed that the range of changes in eye movements suggested changes in the brain stem, as well as the cortical and vestibular pathways. It is known that the central vestibular pathway comprises the vestibular nuclei in the vestibular area of the brainstem rhomboid fossa, vestibulo-oculomotor, vestibulocerebellar, vestibuloreticular, vestibulocortical, vestibulospinal pathways and their connections with the reticular formation (reflex mechanisms, including autonomous ones) and other areas of the CNS. The CNS quickly organizes and processes visual, vestibular and proprioceptive sensory information in specific areas of the brainstem and cerebellum, which orient head, neck, cervical spine, legs, arms, eyes and all body muscle movements[29]. Regarding gender, there was no literature with which to compare our results.
In conclusion, the most evident neurological symptoms found in this group of patients with hereditary ataxias were gait disturbances, dizziness, dysarthria and dysphagia.
Alterations in vestibular examinations occurred in 87% of patients, mostly in the caloric test (79%), with a predominant deficit of central vestibular system dysfunction (70%).
This underscores the importance of the contribution of topodiagnostic labyrinthine evaluations for neurodegenerative diseases as, in most cases, the initial symptoms are otoneurological.